Business Brief -- Marquest Medical Products Inc.:
   FDA Approves the Restart
   Of Two Production Plants
In November and December, the FDA allowed the company to
resume shipments of some products. The company said it may
now distribute products manufactured before the FDA took
action but after the products are tested by the company.
   A company spokesman couldn't be reached for elaboration.